The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study
Open accessAbstract
Dementia is one of the most debilitating symptoms of Parkinson's disease. A recent longitudinal study suggests that up to 80% of patients with Parkinson's disease will eventually develop dementia. Despite its clinical importance, the development of dementia is still difficult to predict at early stages. We previously identified olfactory dysfunction as one of the most important indicators of cortical hypometabolism in Parkinson's disease. In this study, we investigated the possible associations between olfactory dysfunction and the risk of developing dementia within a 3-year observation period. Forty-four patients with Parkinson's disease without dementia underwent the odour stick identification test for Japanese, memory and visuoperceptual assessments, (18)F-fluorodeoxyglucose positron emission tomography scans and magnetic resonance imaging scans at baseline and 3 years later. A subgroup of patients with Parkinson's disease who exhibited severe hyposmia at baseline showed more pronounced cognitive decline at the follow-up survey. By the end of the study, 10 of 44 patients with Parkinson's disease had developed dementia, all of whom had severe hyposmia at baseline. The multivariate logistic analysis identified severe hyposmia and visuoperceptual impairment as independent risk factors for subsequent dementia within 3 years. The patients with severe hyposmia had an 18.7-fold increase in their risk of dementia for each 1 SD (2.8) decrease in the score of odour stick identification test for Japanese. We also found an association between severe hyposmia and a characteristic distribution of cerebral metabolic decline, which was identical to that of dementia associated with Parkinson's disease. Furthermore, volumetric magnetic resonance imaging analyses demonstrated close relationships between olfactory dysfunction and the atrophy of focal brain structures, including the amygdala and other limbic structures. Together, our findings suggest that brain regions related to olfactory function are closely associated with cognitive decline and that severe hyposmia is a prominent clinical feature that predicts the subsequent development of Parkinson's disease dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
A fast diffeomorphic image registration algorithm
Ashburner, J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.007 · Cited by 8,122
Ashburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. (1990) · Neurology · doi:10.1212/wnl.40.10.1529 · Cited by 1,285
Doty, R. L., Deems, D. A., & Stellar, S. (1988) · Neurology · doi:10.1212/wnl.38.8.1237 · Cited by 838
Dementia associated with Parkinson's disease
Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 685
The epidemiology of dementia associated with Parkinson disease
Aarsland, D., & Kurz, M. W. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.034 · Cited by 578
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Burn, D. J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 436
The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.
Mohs, R. C., Rosen, W. G., & Davis, K. L. (1983) · PubMed · Cited by 425
Defining mild cognitive impairment in Parkinson's disease
Caviness, J. N., Driver‐Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., Evidente, V. G. H., Shill, H. A., & Adler, C. H. (2007) · Movement Disorders · doi:10.1002/mds.21453 · Cited by 422
The progression of pathology in longitudinally followed patients with Parkinson’s disease
Halliday, G., Hely, M., Reid, W., & Morris, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0344-8 · Cited by 414
Olfactory Functions Are Mediated by Parallel and Hierarchical Processing
Savic, I., Gulyas, B., Larsson, M., & Roland, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)81209-x · Cited by 397
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
Bohnen, N. I., Muller, M. L. T. M., Kotagal, V., Koeppe, R. A., Kilbourn, M. A., Albin, R. L., & Frey, K. A. (2010) · Brain · doi:10.1093/brain/awq079 · Cited by 316
Unified Parkinson’s Disease Rating Scale
Fish, J. (2011) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-0-387-79948-3_1836 · Cited by 297
Amygdala pathology in Parkinson's disease
Braak, H., Braak, E., Yilmazer, D., de Vos, R. A. I., Jansen, E. N. H., Bohl, J., & Jellinger, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00296485 · Cited by 295
Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0705-2 · Cited by 228
Welbourn, R., & Buxton, J. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91241-0 · Cited by 224
Molano, J., Boeve, B., Ferman, T., Smith, G., Parisi, J., Dickson, D., Knopman, D., Graff-Radford, N., Geda, Y., Lucas, J., et al. (2010) · Brain · doi:10.1093/brain/awp280 · Cited by 208
BLASS, J. P., SHEU, R. K., & GIBSON, G. E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06370.x · Cited by 199
Regional cerebral blood flow in Parkinson's disease with and without dementia
Firbank, M., Colloby, S. J., Burn, D. J., McKeith, I. G., & O'Brien, J. T. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00364-1 · Cited by 174
Development of a Smell Identification Test Using a Novel Stick-Type Odor Presentation Kit
Saito, S., Ayabe-Kanamura, S., Takashima, Y., Gotow, N., Naito, N., Nozawa, T., Mise, M., Deguchi, Y., & Kobayakawa, T. (2006) · Chemical Senses · doi:10.1093/chemse/bjj042 · Cited by 170
Borght, T. V., Minoshima, S., Giordani, B., Foster, N. L., Frey, K. A., Berent, S., Albin, R. L., Koeppe, R. A., & Kuhl, D. E. (1997) · PubMed · Cited by 160
Olfactory Impairment Predicts Brain Atrophy in Parkinson's Disease: Figure 1.
Wattendorf, E., Welge–Lüssen, A., Fiedler, K., Bilecen, D., Wolfensberger, M., Fuhr, P., Hummel, T. R., & Westermann, B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1909-09.2009 · Cited by 153
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
Kalaitzakis, M. E., Christian, L., Moran, L. B., Graeber, M. B., Pearce, R. K. B., & Gentleman, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.007 · Cited by 150
Yong, S. W., Yoon, J., An, Y., & Lee, P. H. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01977.x · Cited by 143
Levodopa therapy and survival in idiopathic Parkinson's disease
Uitti, R. J., Ahlskog, J. E., Maraganore, D. M., Muenter, M. D., Atkinson, E. J., H., R., & O’Brien, P. C. (1993) · Neurology · doi:10.1212/wnl.43.10.1918 · Cited by 136
Hosokai, Y., Nishio, Y., Hirayama, K., Takeda, A., Ishioka, T., Sawada, Y., Suzuki, K., Itoyama, Y., Takahashi, S., Fukuda, H., et al. (2009) · Movement Disorders · doi:10.1002/mds.22444 · Cited by 132
Self-citationRegional differences in the severity of Lewy body pathology across the olfactory cortex
Silveira‐Moriyama, L., Holton, J. L., Kingsbury, A. E., Ayling, H., Petrie, A., Sterlacci, W., Poewe, W. H., Maier, H., Lees, A. J., & Révész, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.006 · Cited by 130
Alpha‐synuclein pathology in the olfactory pathways of dementia patients
Hubbard, P. S., Esiri, M. M., Reading, M. C., McShane, R. H., & Nagy, Z. (2007) · Journal of Anatomy · doi:10.1111/j.1469-7580.2007.00748.x · Cited by 105
Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease
Baba, T., Takeda, A., Kikuchi, A., Nishio, Y., Hosokai, Y., Hirayama, K., Hasegawa, T., Sugeno, N., Suzuki, K., Mori, E., et al. (2011) · Movement Disorders · doi:10.1002/mds.23602 · Cited by 89
Self-citationOlfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease
Morley, J. F., Weintraub, D. A., Mamikonyan, E., Moberg, P. J., Siderowf, A. D., & Duda, J. E. (2011) · Movement Disorders · doi:10.1002/mds.23792 · Cited by 86
Stephenson, R., Houghton, D. J., Sundarararjan, S., Doty, R. L., Stern, M., Xie, S. X., & Siderowf, A. D. (2010) · Movement Disorders · doi:10.1002/mds.23234 · Cited by 71
Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour
Abe, N., Fujii, T., Hirayama, K., Takeda, A., Hosokai, Y., Ishioka, T., Nishio, Y., Suzuki, K., Itoyama, Y., Takahashi, S., et al. (2009) · Brain · doi:10.1093/brain/awp052 · Cited by 69
Self-citationCorticolimbic gray matter loss in Parkinson’s disease without dementia
Nishio, Y., Hirayama, K., Takeda, A., Hosokai, Y., Ishioka, T., Suzuki, K., Itoyama, Y., Takahashi, S., & Mori, E. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02980.x · Cited by 67
Self-citationEFFECT OF L-DOPA ON COURSE OF PARKINSON'S DISEASE
Curtis, L. D., Lees, A. J., Stern, G. M., & Marmot, M. G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90493-8 · Cited by 54
Docherty, M. J., & Burn, D. J. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0113-7 · Cited by 34
Illusory misidentifications and cortical hypometabolism in Parkinson's disease
Ishioka, T., Hirayama, K., Hosokai, Y., Takeda, A., Suzuki, K., Nishio, Y., Sawada, Y., Takahashi, S., Fukuda, H., Itoyama, Y., et al. (2011) · Movement Disorders · doi:10.1002/mds.23576 · Cited by 27
Self-citation
Cited by
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150642 · Cited by 573
The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study)
Pont‐Sunyer, C., Hotter, A., Gaig, C., Seppi, K., Compta, Y., Katzenschlager, R., Mas, N., Hofeneder, D., Brücke, T., Bayés, A., et al. (2015) · Movement Disorders · doi:10.1002/mds.26077 · Cited by 511
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Svenningsson, P., Westman, E., Ballard, C., & Aarsland, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70152-7 · Cited by 499
Predictors of dementia in Parkinson disease: A prospective cohort study
Anang, J. B. M., Gagnon, J.-F., Bertrand, J.-A., Romenets, S. R., Latreille, V., Panisset, M., Montplaisir, J., & Postuma, R. B. (2014) · Neurology · doi:10.1212/wnl.0000000000000842 · Cited by 379
Olfactory bulb involvement in neurodegenerative diseases
Attems, J., Walker, L., & Jellinger, K. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1261-7 · Cited by 342
Metadata
- Authors
- Baba, T., Kikuchi, A., Hirayama, K., Nishio, Y., Hosokai, Y., Kanno, S., Hasegawa, T., Sugeno, N., Konno, M., Suzuki, K., Takahashi, S., Fukuda, H., Aoki, M., Itoyama, Y., Mori, E., & Takeda, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01
- Volume
- 135
- Issue
- 1
- Pages
- 161-169
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2142470915
- Cited by
- 284
- References
- 43
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.